Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cisplatin and 5-FU vs. the same plus bleomycin and methotrexate in recurrent squamous cell carcinoma of the head and neck

Cisplatin and 5-FU vs. the same plus bleomycin and methotrexate in recurrent squamous cell carcinoma of the head and neck. ASCO. 1990; 9: 175 (#676).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.